Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men

Journal of Alzheimer's Disease

Volumn 21, Issue 4, 2010, Pages 1335-1345

  Chu, Leung Wing ^a,b   Tam, Sidney ^a,b   Wong, Rachel L C ^a,b   Yik, Ping Yiu ^a   Song, Youqiang ^a,b   Cheung, Bernard M Y ^a,b   Morley, John E ^c   Lam, Karen S L ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alzheimer's disease; Chinese; men; testosterone

Indexed keywords

APOLIPOPROTEIN E4; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ALZHEIMER DISEASE; AMBULATORY CARE; ARTICLE; BLOOD SAMPLING; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; EDUCATIONAL STATUS; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SENESCENCE; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL;

EID: 78650476837     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100027     Document Type: Article

References (45)

1. Morley JE, Kaiser FE, Raum WJ, Perry HM III, Flood JF, Jensen J, Silver AJ, Roberis E (1997) Potentially predicative and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci USA 94, 7537-7542.
2. Morley JE, Kaiser FE, Perry 3rd HM, Patrick P, Morley PMK, Stauber PM, Vellas B, Baumgartner RN, Garry PJ (1997) Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 46, 410-413.
3. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86, 724-731.
4. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB (2002) Age trends in the level ofserum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 87, 589-598.
5. Chu LW, Tam S, Kung AW, Lo S, Fan S, Wong RL, Morley JE, Lam KS (2008) Serum total and bioavailable testosterone levels, central obesity and muscle strength changes with aging in healthy Chinese men. J Am Geriatr Soc 56, 1286-1291.
6. Moffat SD, Zonderman AB, Metter EJ, Blackman MR, Har-man SM, Resnick SM (2002) Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 87, 5001-5007.
7. Fonda SJ, Bertrand R, O'Donnell A, Longcope C, McKinlay JB (2005) Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study. J Gerontol Series A Med Sci 60, 385-390.
8. Yaffe K, Lui L-Y, Zmuda J, Cauley J (2002) Sex hormones and cognitive function in oldermen. J Am GeriatSoc 50, 707-712.
9. Yaffe K, Barnes D, Lindquist K, Cauley J, Simonsick EM, Penninx B, Satterfield S, Harris T, Cummings SR; Health ABC Investigators (2007) Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol Aging 28, 171-178.
10. Hogervorst E, Bandelow S, Combrinck M, Smith AD (2004) Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol 39, 1633-1639. (Pubitemid 39576135)
11. Paoletti AM, Congia S, Lello S, Tedde D, Orru M, Pistis M, Pilloni M, Zedda P, Loddo A, Melis GB (2004) Low an-drogenization index in elderly women and elderly men with Alzheimer's disease. Neurology 62, 301-303.
12. Okun MS, DeLong MR, Hanfelt J, Gearing M, Levey A (2004) Plasma testosterone levels in Alzheimer and Parkinson diseases. Neurology 62, 411-413.
13. Chu LW, Tam S, Lee PW, Wong RL, Yik PY, Tsui W, Song Y, Cheung BM, Morley JE, Lam KS (2008) Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men. Clin Endocrinol (Oxf) 68, 589-598.
14. Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM & Resnick SM (2004) Free testosterone and risk for Alzheimer disease in older men. Neurology 62, 188-193.
15. Suravarapu S, Bergstralh EJ, Farmer SA, Knopman DS, Ja-cobsen SJ, Roberts RO (2006) Dementia and low testosterone and bioavailable testosterone levels in men: possible increased risk. Alzheimer Dis Assoc Disord 20, 138-140.
16. Ravaglia G, Forti P, Maioli F, Bastagli L, Montesi F, Pisacane N, Chiappelli M, Licastro F, Patterson C (2007) Endogenous sex hormones as risk factors for dementia in elderly men and women. J Gerontol A Biol Sci Med Sci 62, 1035-1041.
17. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC, USA: American Psychiatric Association, Text Revision (DSM-IV-TR) pp. 83-98.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34, 939-944.
19. Chu LW, Tam S, Lee PW, Yik PY, Song YQ, Cheung BM, Lam KS (2009) Late-life body mass index and waist circumference in amnestic mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 17, 223-232.
20. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A New Clinical Rating Scale for the Staging of Dementia. Br J Psychiatry 140, 566-572.
21. Chiu HF, Lee HC, Chung WS, Kwong PK (1994) Reliability and Validity of the Cantonese Version of Mini-Mental State Examination -A Preliminary Study. J Hong Kong Coll Psy-chiatr 4, 25-28.
22. Chu LW, Chiu KC, Hui SL, Yu GK, Tsui WJ, Lee PW (2000) The reliability and validity ofthe Alzheimer's Disease Assessment Scale cognitive Subscale (ADAS-cog) among the elderly Chinese in Hong Kong. Ann Acad Singapore 29, 478-485.
23. Li Y, Chu LW, Chen YQ, Cheung BMY, Leung RYH, Yik PY, Ng KM, Mak W, Jin DY, st. George-Hyslop P, Song YQ (2006) Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese. Dement Geriatr Cogn Disorder 22, 399-404.
24. Chiu HF, Lee HC, Wing YK, Kwong PK, Leung CM, Chung DW (1994) Reliability, validity and structure of the Chinese Geriatric Depression Scale in a Hong Kong context: a preliminary report. Singapore Med J 35, 477-80.
25. Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grund-man M, Ferris S (1997) An inventory to assess the activities of daily living for clinical trials in Alzheimer's disease The Alzheimer's Disease Cooperative Study. AlzDis Assoc Disord 11(suppl 2), S33-S39.
26. Morley JE, Patrick P, Perry HM 3rd (2002) Evaluation of assays available to measure free testosterone. Metabolism 51, 554-559.
27. Hixson JE and Vernier TV (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31, 545-548.
28. Chu LW, Li Y, Li Z, Tang AY, Cheung BM, Leung RY, Yik PY, Jin DY, Song YQ (2007) A novel intronic polymorphism of ABCA1 gene reveals risk for sporadic Alzheimer's disease in Chinese. Am J Med Genet B Neuropsychiatr Genet 144B, 1007-1013.
29. Li Y, Chu LW, Li Z, Yik PY, Song YQ (2009) A study on the association ofthe Chromosome 12p13 locus with sporadic late-onset Alzheimer's disease in Chinese. Dement Geriatr Cogn Disord 27, 508-512.
30. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58, 19851992.
31. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56, 303-308. (Pubitemid 29120227)
32. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmen E, Waring SC, Kurland LT (1995) Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 273, 1274-1278.
33. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Van-hanen H, Webster J, Yodfat Y, Fagard R (1998) Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352, 1347-1351.
34. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813-817.
35. Rosario ER, Chang L, Stanczyk FZ, Pike CJ (2004) Age-related testosterone depletion and the development of Alzheimer disease. JAMA 292, 1431-1432.
36. Rosario ER, Chang L, Head EH, Stanczyk FZ, Pike CJ (2009) Brain levels ofsex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging, in press.
37. Pike CJ (2001) Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons. Brain Res 919,160-165.
38. Papasozomenos SC, Shanavas A (2002) Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphos-phorylation of tau: implications for Alzheimer's disease. Proc Natl Acad Sci USA 99, 1140-1145.
39. Flood JF, Farr SA, Kaiser FE, La Regina M, Morley JE (1995) Age-related decrease of plasma testosterone in SAMP8 mice: replacement improves age-related impairment of learning and memory. Physiol Behav 57, 669-673.
40. Cherrier MM, Asthana S, Plymate S, Baker L, Matsumoto AM, Peskind E, Raskind MA, Brodkin K, Bremner W, Petrova A, LaTendresse S, Craft S (2001) Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 57, 80-88.
41. Cherrier MM, Matsumoto AM, Amory JK, Asthana S, Brem-ner W, Peskind ER, Raskind MA, Craft S (2005) Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology 64, 2063-2068.
42. Tan RS, Pu SJ (2003) A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Aging Male 6, 13-17.
43. Kenny AM, Fabregas G, Song C, Biskup B, Bellantonio S (2004) Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci 59, 75-78.
44. Maki PM, Ernst M, London ED, Mordecai KL, Perschler P, Durso SC, Brandt J, Dobs A, Resnick SM (2007) Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J Clin Endocrinol Metab 92,4107-4114.
45. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B (2006) Mild cognitive impairment. Lancet 367, 1262-1270.